Inventor
CHAN MING FAI
US21 patents
⚠️ This page may combine multiple inventors who share the name “CHAN MING FAI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
TEXAS BIOTECHNOLOGY CORP
11 patentsUS5962490AOct 5, 1999
Thienyl-, furyl- and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
TEXAS BIOTECHNOLOGY CORP93 citations96
US5571821ANov 5, 1996
Sulfonamides and derivatives thereof that modulate the activity of endothelin
TEXAS BIOTECHNOLOGY CORP125 citations96
US5977117ANov 2, 1999
Substituted phenyl compounds and derivatives thereof that modulate the activity of endothelin
TEXAS BIOTECHNOLOGY CORP72 citations95
US6376523B1Apr 23, 2002
Benzenesulfonamides and the use thereof to modulate the activity of endothelin
TEXAS BIOTECHNOLOGY CORP19 citations92
US6331637B1Dec 18, 2001
N-Alkyl, N-Alkenyl, N-Alkynyl, N-Aryl and N-fused bicyclo or tricyclo thienyl-, furyl-,and Pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
TEXAS BIOTECHNOLOGY CORP26 citations92
US6265428B1Jul 24, 2001
Substituted phenyl compounds and derivatives thereof that modulate the activity of endothelin
TEXAS BIOTECHNOLOGY CORP34 citations92
US6030991AFeb 29, 2000
Benzenesulfonamides and the use thereof to modulate the activity of endothelin
TEXAS BIOTECHNOLOGY CORP47 citations92
US5736509AApr 7, 1998
Cyclic peptide surface feature mimics of endothelin
TEXAS BIOTECHNOLOGY CORP19 citations92
US6342610B2Jan 29, 2002
N-aryl thienyl-, furyl-, and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
TEXAS BIOTECHNOLOGY CORP18 citations83
US6384261B1May 7, 2002
Phosphoramidates, phosphinic amides and related compounds and the use thereof to modulate the activity of endothelin
TEXAS BIOTECHNOLOGY CORP5 citations73
US5958905ASep 28, 1999
Phosphoramidates, phosphinic amides and related compounds and the use thereof to modulate the activity of endothelin
TEXAS BIOTECHNOLOGY CORP10 citations73
ALLERGAN INC
5 patentsUS5476872ADec 19, 1995
1,11-diesters of prostaglandin-F2α having a polar ester group at C-1
ALLERGAN INC22 citations92
US5656635AAug 12, 1997
5-trans-alcohols and their use as ocular hypotensives
ALLERGAN INC7 citations74
US5574066ANov 12, 1996
Intraocular pressure reducing 15-acyl prostaglandins
ALLERGAN INC12 citations74
US5312842AMay 17, 1994
Cyclopentane heptenylsulfinylalkyl and heptanylsulfinylalkyl-2-aliphatic or aryl aliphatic derivatives
ALLERGAN INC9 citations74
US5262437ANov 16, 1993
Homo-prostaglandin derivatives as ocular hypotensives
ALLERGAN INC17 citations74